BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23805290)

  • 1. Differential Changes in Expression of Stress- and Metabolic-Related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and Withdrawal.
    Pintér-Kübler B; Ferenczi S; Núnez C; Zelei E; Polyák A; Milanés MV; Kovács KJ
    PLoS One; 2013; 8(6):e67027. PubMed ID: 23805290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal.
    Nunez C; Földes A; Laorden ML; Milanes MV; Kovács KJ
    J Neurochem; 2007 May; 101(4):1060-71. PubMed ID: 17286593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress.
    Makino S; Asaba K; Nishiyama M; Hashimoto K
    Neuroendocrinology; 1999 Sep; 70(3):160-7. PubMed ID: 10516478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo-pituitary-adrenal activity after withdrawal from intermittent morphine treatment.
    Houshyar H; Manalo S; Dallman MF
    J Neurosci; 2004 Oct; 24(42):9414-24. PubMed ID: 15496677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: an in situ hybridization study.
    Laorden ML; Milanés MV; Angel E; Tankosic P; Burlet A
    J Neuroendocrinol; 2003 Jun; 15(6):586-91. PubMed ID: 12716409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in metabolic-related variables during chronic morphine treatment.
    Ferenczi S; Núñez C; Pintér-Kübler B; Földes A; Martín F; Márkus VL; Milanés MV; Kovács KJ
    Neurochem Int; 2010 Oct; 57(3):323-30. PubMed ID: 20600437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexigenic effects of endomorphin-2 (EM-2) related to decreased CRH gene expression and increased dopamine and norepinephrine activity in the hypothalamus.
    Brunetti L; Ferrante C; Orlando G; Recinella L; Leone S; Chiavaroli A; Di Nisio C; Shohreh R; Manippa F; Ricciuti A; Mollica A; Vacca M
    Peptides; 2013 Oct; 48():83-8. PubMed ID: 23916912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus.
    Wardlaw SL; Kim J; Sobieszczyk S
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):140-7. PubMed ID: 8883945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 regulates the expression of hypothalamic neuropeptides involved in body weight in a gender-dependent way.
    Señarís RM; Trujillo ML; Navia B; Comes G; Ferrer B; Giralt M; Hidalgo J
    J Neuroendocrinol; 2011 Aug; 23(8):675-86. PubMed ID: 21564350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress.
    Zhou Y; Spangler R; Maggos CE; Wang XM; Han JS; Ho A; Kreek MJ
    J Endocrinol; 1999 Nov; 163(2):261-7. PubMed ID: 10556776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin that produces reduced food and water intake induces long-lasting expression of corticotropin-releasing factor, arginine vasopressin, and proopiomelanocortin in rat brain.
    Moon BH; Hong CG; Kim SY; Kim HJ; Shin SK; Kang S; Lee KJ; Kim YK; Lee MS; Shin KH
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):314-22. PubMed ID: 18824019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital vasopressin deficiency and acute and chronic opiate effects on hypothalamo-pituitary-adrenal axis activity in Brattleboro rats.
    Domokos A; Mergl Z; Barna I; Makara GB; Zelena D
    J Endocrinol; 2008 Jan; 196(1):113-21. PubMed ID: 18180322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of antral and proximal colonic motility induced by chronic psychological stress involves central urocortin 3 and vasopressin in rats.
    Ataka K; Nagaishi K; Asakawa A; Inui A; Fujimiya M
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G519-28. PubMed ID: 22651925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin regulates appetite-related neuropeptides in the hypothalamus of developing rats without affecting food intake.
    Proulx K; Richard D; Walker CD
    Endocrinology; 2002 Dec; 143(12):4683-92. PubMed ID: 12446596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of subcutaneous leptin injections on hypothalamic gene profiles in lean and ob/ob mice.
    Duan J; Choi YH; Hartzell D; Della-Fera MA; Hamrick M; Baile CA
    Obesity (Silver Spring); 2007 Nov; 15(11):2624-33. PubMed ID: 18070753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenalectomy enhances endotoxemia-induced hypophagia: higher activation of corticotrophin-releasing-factor and proopiomelanocortin hypothalamic neurons.
    Rorato R; Castro M; Borges BC; Benedetti M; Germano CM; Antunes-Rodrigues J; Elias LL
    Horm Behav; 2008 Jun; 54(1):134-42. PubMed ID: 18374921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal.
    Ammon S; Mayer P; Riechert U; Tischmeyer H; Höllt V
    Brain Res Mol Brain Res; 2003 Apr; 112(1-2):113-25. PubMed ID: 12670709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes.
    Schwartz MW; Strack AM; Dallman MF
    Regul Pept; 1997 Oct; 72(2-3):105-12. PubMed ID: 9652969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
    Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.